SHINE Signs Contract with DOE
SHINE Technologies announced today that it has signed a contract with the Department of Energy as part of its Uranium Lease and Take-back Program. According to a release, SHINE will…
Tag Archives: SHINE Medical Technologies
SHINE Announces Name Change
SHINE Medical Technologies has changed its name to SHINE Technologies, the company announced today. According to a release, the new name highlights the company’s core technological competencies, skilled team and…
SHINE Closes $150M Series C-5 Financing
SHINE Medical Technologies has completed a $150 million Series C-5 financing round led by Koch Disruptive Technologies (KDT), with participation from Fidelity Management & Research Company, Baillie Gifford and other…
SHINE to Build Facility in Europe
SHINE Medical Technologies will build its European medical isotope production facility in the Netherlands, the company announced today. According to a release, the European facility, which will be located in…
SHINE, Phoenix Merge
SHINE Medical Technologies and Phoenix have completed a merger under which Phoenix has become a wholly owned subsidiary of SHINE, the companies announced today. “SHINE and Phoenix have shared a…
SHINE Announces Weathertight Facility, Board Members
SHINE Medical Technologies has completed exterior construction of its medical isotope production facility and made it weathertight for protection, the company announced today. According to a release, the facility can withstand…
SHINE Breaks Ground on HQ
SHINE Medical Technologies broke ground on its 54,000-square-foot corporate headquarters and therapeutics production facility in Janesville, Wis., the company announced recently. “The best work we do at SHINE is the…
SHINE to Add a Supercell to Facility
SHINE Medical Technologies will add a “supercell,” a bank of 10 hot cells, for its medical isotope production facility in Janesville, Wis., the company announced recently. According to a release,…
SHINE Makes First Sale of Lu-177 Isotope
SHINE Medical Technologies Therapeutics division has made its first commercial sale of lutetium-177, a therapeutic isotope in demand by clinical trial sponsors, the company announced recently. “This milestone is really exciting,…
SHINE Closes $80M Series C
SHINE Medical Technologies has closed an $80 million Series C financing round, the company announced recently. “This funding round will help SHINE’s continuing efforts to commercialize vital diagnostic and therapeutic…
